far beyond the region, while russia continues to batter ukraine, that war has largely disappeared from the headlines and us weapons. men for ukraine have been move closer to israel instead of development. russia generally welcomes, but if the rain and regime falls small scale would also lose its most valuable ally in the middle east. so russia has offered to mediate a does seem like despite all the tough talk, there really is still room and time for diplomacy. trump says he will decide in the next 2 weeks whether to get his military involved. i'm gonna go for lincoln, berlin, and this is the day i of the time i can make the final decision one second before i trust the judgement is a tremendous rather tremendous. we're leader,

a tremendous friend of israel and the jewish people, just the nuclear. she has to be pretty dealt with by way of negotiation. they do want to come and see it. so they want to see me in the white house, if they say not to send dismissal. we don't know what the contact is going to talk to the moment the secretion is thoughts. of course the policies is the 1st option around can not have enough and i think there were a few weeks away from having also on the day the us approves a new injectable drug that prevents h i v. we speak to one of the world's leading experts on the virus about what the breakthrough means. in both trials, the results are just extraordinary. for women, the advocacy was a 100 percent. and typically we see lower rates of effectiveness for prevention in women than men. so this really is a game changer, but the big issue is going to be access,

getting it out there to the people who need it. the welcome to the show. we begin the day with the choice facing us president donald trump fights or talk. trump says he has not yet decided on whether to join israel and it strikes on or runs nuclear facilities. now he has given the world a timeframe for his decision. within the next 2 weeks, he says he wants to give negotiations on a nuclear deal with tear on a chance, but those negotiations seem to be going nowhere. the president claims the radians have offered to come to the white house to talk, but they denied that. and said they only know, go sheet if israel stops as bombing campaign, what am i putting things he can bring israel and iran to the negotiating table. russia and iran are closed and tear on has supplied personal weapons for the war and ukraine. at the same time, the kremlin is striving for good relations with israel, part of its delicate balancing act in the middle east. but the us president was

dismissive of hooton's offer to mediate saying, sort out your own problems 1st. to do me a favor. media, your list redid ratio for our so i said louder way. let's media russia 1st so you can worry about this later on. we can now speak to another source of sky. she's a senior fellow at the washington institute, where she focuses on russia's policy towards the middle east and are welcome to the show. now trump there reminding food of his own war. but just give us a sense of how please put in is right now to see the world distracted by what's happening between israel and to run well, i think who is watching these events with a lot of caution. he is a, i don't think he wants to see a major conflict break out to the extent that it necessitates russia diverting more resources to it, that it needs to put at the same time. i think he's looking to leverage this crisis

to his own advantage. and, and that is what he has offered to me that is precisely about we'll get to that offer of mediation in a 2nd. but 1st i want to look at what all of this means for ukraine. we saw on at the g 7. hardly anyone was really concerned with the war in ukraine. donald trump didn't stay to meet with loader mirrors, the lensky. how frustrating is all of this for you cream? still very much fighting for its survival. it is frustrating and i think of zaleski is comments. shortly after this is really strikes on iran with quite towing. he highlighted that a rising oil prices could benefit russia. he raised concerns about weapons being diverted from ukraine to the middle east. and certainly, and again, this goes to your earlier question is why didn't your improvement please? so i think these are valid concerns and of course of,

of food and continuous attacking ukraine that has, that has not changed. how dangerous is all of this for you frame? well i think so, oh, you know, and that there, there's 2 parts here, but as far as weapons deliveries or any kind of military assistance to ukraine, as far as i know, there has been no change. but if there is a rise, an oil prices an extremely thus far, it hasn't quite played out as expected that there was a brief spike of about 7 percent for several days and prices went down. but if there is a serious spike in oil prices, that would be of benefit to russia for sure. because that that is how that's that, that is how rush of funds it's more on ukraine and ukrainians. i think have reasons to be concerned that the middle east could potentially divert attention away from

ukraine. secondly, again, food is offered to mediate if a little product is given that opportunity. and by the way, right now, there's lots of skepticism about that, but it's put is given that opportunity, that would certainly, that would certainly be back for your brain. mm hm. but let's look at the downside for moscow before we look at that offer of mediation, iran has been supplying weapons. most famously of course, the shot had drones to russia. now, one would presume that iran is going to keep all his weapons work and see and use them. is that going to affect russia on the battlefield in ukraine at all? so that you know, that i think is unlikely to effect russia in any negative way. been in any, in any serious way, because the fact of the matter is russia has long since reverse engineering these drones and they found alternative supply chains. it is true that iran has done a lot to enable russia's war,

but russia resented this dependence on iran. this was quite unusual for russia. russia wants others to be dependent on it, and that's why they've taken steps to move away from that dependence. so i think as far as drones, russia has little to worry about me earlier this year, fashion assign a comprehensive strategic partnership with ron. could that put russia in an awkward position of maybe having to assist around militarily? i'm not nearly as much as many have suggested because if you look at the language of the strategic partnership, it does not obligate russia to come to run the 8 that there's nothing that explicitly states see that the 2 countries have to assist each other involuntarily . and in fact, putting actually set as much just the other day of the other issue is that iran does not ask russia for assistance. so there is a strategic partnership with and make no mistake, by the way, russia and iran have

a close partnership of it. and that is very important in terms of pollutants, global emissions and calculations. but what russia, at this stage is not required it to come to the grounds rescue. what about if the around in regime gets toppled? russia already lost an ally in the middle east in the form of syrian president, bashar on the side. what was the loss of its most important ally in the region mean? well, i think that is the one scenario that i put in here. so i think that and, and you, when you asked earlier, how is put in looking at this and this, the scenario unfolding. i do think that that is the one thing that would deal. and unfortunately she didn't blow to him far more so frankly, than the fall of a side resume change into ron would, would be part it would be very would be very bad for in terms of pressures overall

strategic calculus in the middle east and globally. and i think that again, i think that's why he's watching these events with, with a great degree of, of caution. and that's presumably why he wants to mediate. but can moscow really be considered a serious piece broker in this conflict its own more of aggression design. oh no, no law school cannot be considered a neutral mediator in this conflict. frankly, it is if you creative side of the fact of the matter as well on the one hand important has positioned himself in the region. as somebody could talk to all sides, he played this game of, of piece me co peacemaker and peace broker. but the fact of the matter is, he has always leaned closer to anti western forces in the region, and that is iran. it's proxies. and until recently, the offset regime, this, after the latter is put to has done a lot to him power iran, and it's proxies. and so he,

he is by no means neutral that the 2 of them have been aligned on a bigger strategic revision. and that is the reduction of american influence in the middle east. and frankly, a degree of tales in the region to the extent that and benefits these parties. so as to what extent do you think iran really trusts mosque out here? because when the rebels and serial were moving on, damascus, he did not lift a finger or to come to the charlotte, sobs defense. so that could that be a scenario that we see play out again? or do they think that really if push comes to shove, let them improve and if someone that they could ask for help oh, well there, there has been some rumor someone confirmed rumors of a family members of their gym fleeing to moscow. the fact of the matter is there's a lot going on behind the scenes that we simply don't know about at the, at the stage. but, but it is, you know,

it is striking that the running average him as of now has not as pressure for help . your example earlier that you're referring to the us side. it's true that putting it appears to have made a quick decision to let us not fall, but he did give him refuge in moscow, which he didn't have to do. in this scenario, what you're describing has the potential of, again putting out on a much bigger scale where if there is a potential for regime change. again it is, as i said earlier, i think that's the one thing that proven fears the most. because that would be a damaging to his position up in the region. so here i think that opens a lot of questions in real terms and maybe looking at the time also to wrap up, what do you expect to be the short term consequences for ukraine and all of this? i think the, i think if again, any kind of attention give

a taken away from the, from ukraine in any kind of opportunities that russia uses to raise additional revenue for the war already. the fact that there is no discussion of peace talks, i imagine, is, is worrying for zalesky. but having said that, remember, russian does not want peace operations, not looking for peace in ukraine. that's why it, any of these discussions that we seen are not serious because russia is not interested in peace. russia worship believes that he can win this war so. so i think again of diverging attention away from ukraine at this stage would be, would be bad for, for the fingerprint. that was on, of course has kaya the washington institute. many thanks. great speaking to you today. thanks for having it's being held as a big advance in ending the global h i. v epidemic the food and drug administration in the united states has approved

and injectable drugs that prevents h i v infection known under the generic name, lena cap of year. the drug was almost 100 percent effective at stopping the spread of h r b. in large trials. it was developed by the pharmaceutical company, gilly ad and is administered by a to injections every year. and the world health organization has welcome the approval saying we're working with partners and national authorities to ensure lena chavira reaches people who need it most quickly, safely and equitably is estimated that more than 88000000 people have become infected with h. i v. since the 1st cases were reported back in 1981 and of those 42000000 people have died from illnesses related to the virus. in 2023. around 40000000 people were living with h. i be worldwide. advances and therapies have drastically reduced death since the

peak around 20 years ago. christ buyer has for decades, been a leading figure in a chevy prevention treatment and research. he's currently the director of the duke of global health institute. chris, pleasure to have you on the www. today now the u. n. wants to see no new cases of h. i v by 2030. currently we stand at around $1300000.00 new annual documented cases. how much closer are we to the u. n's goal today? well, we're further off that we've been in a while we were supposed to by 2025, we were supposed to have fewer than half a 1000000 new infections a year. so we have missed that target. but in the last 4 months, since the new u. s. administration has come in, many of the programs that were helping us get to the goal, have been drastically cuts. and so we're, we're really in a new era of crisis in global h, i b. how much closer could lena cap of we're put us to achieving that goal?

maybe later than expected or may meet later than wanted. but could that be an important, unimportant moment we're witnessing here. there's no question, let a captive year, and just so your audience knows this is a twice a year injection. it's given subcutaneous lead, and it is an antiviral that prevents age of the acquisition. we have 2 big trials, one entirely in sub saharan african women and girls, the other in the americas in gain by sexual man and trans women. and in both trials, the results are just extraordinary. for women, the advocacy was a 100 percent. and typically we see lower rates of effective best for prevention in women than men. so this really is a game changer, but the big issue is going to be access, getting it out there to the people who need it. and julia,

the company which manufacturers this drug has really laid out and ambitious plans for global access, including making available uh, generic manufacturer and they've made licensing voluntary licensing agreements in 6 countries to manufacturer this drug of for the $120.00 or so low and middle income countries globally, and so they are playing their part, but donors and governments are also going to have to play. there's at, let's focus lina, cup of air a little closer. it's a shot, but it's not a vaccine. is it? that's correct. no, it is a, it's what we call a form of pre exposure prophylaxis or prep. it's the use of an antiviral drug, which also by the way, it's license for treatment it's. it's very much a long active treatment option as well. but this new licensure from these to trials

allows us to use this, antiviral drugs, as i said twice a year, subcutaneous injections, and of course, many vaccines have to be given repeatedly or given as boosters. so in terms of the number of injections, the big difference here is that you're going to have to have an injection every 6 months for as long as you need the protection. so it's not of x, e, but it is highly efficacious. and of course, we've never had an age age, i'd be vaccine candidate. they've got anywhere near close to this level of advocacy . now, the means of administration aside, how is this different from, from other prophylactic medicines that are already available? well, we have an oral several oral agents for prep, most of those have to be taken every day. and that has been a real challenge for many people. and what you see over time is that adhere, it's sticking to the regimen and using it as prescribed goes down for many people,

many populations. and we, we have particular challenges as we've seen among women using these products, particularly in sub saharan africa where the biggest numbers are. and so we've been looking for longer acting agents for some time. there already is one injection. that is a preventive injection. that's also license, that's called a cap of tech revere, but that's every 2 months. so it's 6 shots a year. this at twice a year may be easier for people to use. it may be easier for people to use longer term. who is this aimed at? mostly well the, the 1st trial there was a, the, both of these trials were supported by gilly ad was the purpose one trial which was done for young, reproductive age adolescent girls and women in sub saharan africa. and the reason

for that is that in africa, you see it's in part of the world where there is female predominance. there are more infections in women than there are in men. and we have had a terrible time controlling new infections, reducing the number of, you know, infections in this population. so that was the 1st group we really aimed at women and girls in high burden countries of reproductive age. the 2nd group is, is the population that also has very high rates of age. i'd be infection and that is gay and bisexual men transgender women who have sex with man and non bind airy and gender queer persons who also have sex with that. and, and those populations, a oral prep has worked more effectively, but it's still a challenge for people to adhere to use it over time. so the 2nd trial was done in sexual and gender minority populations. and it showed just

a slightly less maybe 99 percent advocacy as opposed to the trial in women where there were no infections and women getting the to the actual drug as opposed to the to see about control. yeah, that's, that's really impressive. so far it has only been approved in the us. so how far are we from approval in other countries as well? gillian has already filed with the world health organization, which is very important in other countries. they've also filed with the european medical, the m a. and that's very important because they're the, the other 2 along with the f d a that many countries will look to for their own approvals. they've also filed in brazil and south africa, a very important countries. um and the generic manufacturer, the licensing agreements that they've made, that's gonna take a couple of years to get up to speed and to get to scale. but go uh is

that they, they are hoping to have a generic, low cost generic manufacturer available. we've been about 3 years and that could, could reach up to 2000000 people. so there really is the potential for a wide use of this drug. but again, it's going to require governments to include it in their national plans. it's going to require donors supporting this for the lowest income countries, where the, where it just even the program costs will be a challenge. it's much less the drug cost. can you see that happening? because right now we're at the moment, we're many a program supporting h i v care and prevention around the globe are facing tremendous financial troubles . absolutely, yes. and it's not just the us there have been declines from germany or country. i'm

sorry to say there was, have been declines in the u. k. the european donors in general have been less interested in, in specific h i v funding and had wanted to do more with funding health system reform, health sector reform. so there been many downward pressures on donor aid for h i v, and aids. but that said, this is a revolution that may or may not happen. we are really not certain of that access is going to be available for all the people who need it. and in time to really make a difference. so i would say this is one of the great challenges facing public health right now is making sure that that we use is this powerful new tool in ways that could really help us get to the end of this pandemic. and it is in some way, it's a critical moment really for the field. yeah. it's a powerful tool, but it's just one brick in the wall of the preventative new h i v cases. isn't that what else is needed to, you know,

one day completely eradicate h i b h? well, we talked earlier here, 1st question to me was about the number of new infections every year. we have right now about something like 28000000 people worldwide living on it's heavy therapy. then we could keep adding every year over a 1000000 new infections. so the burden the prevalence of h, i b is continuing to rise and the number of people who need therapy is continuing to rise. so one approach that some are working on a scientists, but also donors like the gates foundation, is looking at a simpler and more feasible approaches towards sure. actually turing h i b infection. and ultimately, when you look at viral infections and h, i, b is a virus, we have always needed a vaccine. ultimately,

it really does take it back stain, uh and uh, curative strategy. if we had those 2 things, we could truly bring this up a demick to an end. as it is, let a cap of beer, hopefully is going to help us really reduce the number of new infections such that we, we get some ability to control. but you have to remember that all these people who've been recently infected and will have been infected in the last several years. if they have access to any viral therapy can have long, healthy lives up to now about 72 years. that's the life expectancy of somebody newly infected with h i, b, and so the treatment burdens are going to be there for decades to come there's, there's no brakes it on edge i b as chris, bye, or thank you so much for your time. great speaking to you. thank you. good speak to you. so it is very much

a hollywood car chaise, cliche and tiny car hurdling down a famous staircase in a european capital. this time though, there was no stun driver behind the wheel and 81 year old man took a wrong turn in his compact luxury, mercedes in rome this week and ended up on the iconic spanish steps. and once he started going down, well, the only way was further down until he got stuck there. you can see and police say, he seemed confused, but that he was not in a breed. and that's our time. thank you so much for your company. see you again tomorrow the

the view will tell you who we are happy that we are boxing the story. we have a getting a visa is more difficult than finding gold hosted to use the dream force and for the future in the stories and issues that are being discussed across the country. news africa next on dw sizing, called costs, know on tv. my fee is and with i'm going to be

a good model always you can defend yourself that you can break, understand what like to come out when you're married. how does on mental health impact a lot of life between east to west or the cross? is right in the middle of the world around germany. it's getting more dangerous. we de code what it means senior. a 60 minute phone d delta. the is taking the hoods, they've pulled out the guns. this is a war, right wing extremists. they are ruthless, i'm guessing younger. these young people are radicalized in social networks. i am trained politically. they are connected worldwide. old, a warranty is more worn. they want to spread,

say i do all the g across many nations, and then i'm the is on the wrong. there's hundreds more. probably thousands. i think they're all white page stats to lie. 12 on d, w, the, this is the w news, africa coming up on the program. what makes nigerian so vulnerable to narcotics, the number of nigerians getting high is getting higher and many are doing it on the cheap by buying a bag of colors for just a 1000. i wrote as little as 50 euro cents, but there's another price to be paid, whether you with the buyer or the seller. also coming up, the number of people who been driven from their home was by violence, drought, or disease has doubled in the last decade. and a new report from the norwegian refugee council says age of the 10 worst kid countries.